PCYC

Pharmacyclics, Inc. News Headlines

$131.03
*  
1.47
1.13%
Get PCYC Alerts
*Delayed - data as of Dec. 17, 2014  -  Find a broker to begin trading PCYC now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Healthcare Stocks Joining Late Slide for Equities
1/13/2014 3:58:11 PM - MT Newswires


Sector Update: Healthcare
1/13/2014 3:57:38 PM - MT Newswires


Pharmacyclics Soars on Positive Imbruvica News - Analyst Blog
1/8/2014 11:40:01 AM - Zacks.com


Biotech Stock Roundup: Amgen Data Looks Good, CANF Tumbles - Industry Outlook
1/8/2014 10:17:00 AM - Investopedia


ETF Outlook for Wednesday, January 8, 2014 (ROBO, PBE, SMH, EUFN)
1/8/2014 7:31:30 AM - Benzinga


Cramer's Mad Money - My New Year's Resolution For Investing (1/7/14)
1/8/2014 5:40:00 AM - Seeking Alpha


Pharmacyclics: As Imbruvica Commercialization Begins, Sell-Off Creates Opportunity
1/3/2014 10:12:00 AM - Seeking Alpha


Following Smart Money: Baker Brothers Investments In 2013 And Beyond, Part 2
12/30/2013 8:01:00 AM - Seeking Alpha


Will Galena's Post-Holiday Charm Continue?
12/19/2013 11:51:00 AM - Seeking Alpha


Ziopharm: Finally A Winner In The War On Cancer?
12/15/2013 1:22:00 PM - Seeking Alpha


Understanding The Investment Opportunity In Developmental Biotechnology
12/11/2013 6:31:00 PM - Seeking Alpha


PCYC Earns Milestone Payments on Imbruvica - Analyst Blog
11/22/2013 2:30:01 PM - Zacks.com


FDA Panel Positive on BioMarin's Vimizim - Analyst Blog
11/20/2013 11:50:01 AM - Zacks.com


Pharmacyclics Inks Supply Deal - Analyst Blog
11/18/2013 11:40:01 AM - Zacks.com


BioMarin Shoots Up Ahead of FDA Panel - Analyst Blog
11/18/2013 11:30:01 AM - Zacks.com


Good News for Pharmacyclics - Analyst Blog
11/14/2013 11:50:01 AM - Zacks.com


Top Stock Picks: Week of November 11th - Analyst Blog
11/11/2013 7:34:01 PM - Zacks.com


Jazz Pharma Upgraded to Strong Buy - Analyst Blog
11/11/2013 5:00:01 PM - Zacks.com


PCYC Beats on Earnings and Revs in Q3 - Analyst Blog
11/11/2013 9:07:12 AM - Zacks.com


Santarus (SNTS) Catches Eye: Stock Surges 37.6% - Analyst Blog
11/11/2013 9:06:40 AM - Zacks.com


After-Hours Earnings Report for November 7, 2013 : DIS, PCLN, MNST, NVDA, PCYC, MTD, GRPN, NFG, SLXP, WR, GXP, ATW
11/7/2013 2:00:07 PM - NASDAQ.com News


NPSP's Loss Narrows, Shares Down on Weak Forecast - Analyst Blog
11/7/2013 12:05:34 PM - Zacks.com


Auxilium Beats on Earnings & Revs - Analyst Blog
11/7/2013 11:05:12 AM - Zacks.com


Cramer's Lightning Round - I'm Not Deviating From Delta (11/4/13)
11/5/2013 6:09:00 AM - Seeking Alpha


Are You Betting Too Much On Theravance?
11/1/2013 11:28:00 AM - Seeking Alpha